A novel long-term prediction model showed promise at estimating the risk for dying of prostate cancer, an analysis published ...

Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8 men will be diagnosed with prostate ...

CDX Prostate is a blood-based diagnostic tool that uses AI-powered learning to determine the risk of aggressive prostate cancer. Florida-based Protean BioDiagnostics will now offer the validated CDX ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment intensification can meaningfully improve survival for patients with ...

CLEVELAND, Ohio — When it comes to cancer, deciding on the best course of treatment can sometimes feel like a coin toss. However, doctors at University Hospitals have a new tool that helps them weigh ...

The UCLA trial is currently enrolling patients.

News that former President Joseph Biden has advanced prostate cancer has revived long-standing questions about the benefits versus the harms of a blood test that screens for the most commonly ...

Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population. A post-hoc ...